Apremilast
Apremilast was ranked 1401st of 1,792 medicines by items in May 2026, with 21 items, up 23.5% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Apremilast: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
At a glance
- Therapeutic class Drugs used in rheumatic diseases and gout
- Presentations 2 shown
- Average cost / item £1,077.55
- Year on year Up 23.5% on a year earlier
Top presentations, May 2026
The individual products dispensed under Apremilast this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Otezla 30mg tablets | 1001030AABBAAAA | 7 | £10,450 |
| Apremilast 30mg tablets | 1001030AAAAAAAA | 14 | £12,179 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Apremilast is dispensed
The regions and dispensing practices with the highest Apremilast volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
In NHS hospitals
Apremilast is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.
Compare Apremilast with
Other medicines in the same BNF section, by prescribing volume.